SCHEMBL9877216

SCHEMBL9877216

C=CCN1CCC(CN)C1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.39
SIGMAR1 Q99720 1/20 0.37
BPTF Q12830 1/20 0.35
CXCR4 P61073 1/20 0.34
DRD3 P35462 2/20 0.33
DRD2 P14416 1/20 0.33
OPRM1 P35372 1/20 0.33
PRMT3 O60678 1/20 0.32
CARM1 Q86X55 1/20 0.32
PRMT6 Q96LA8 1/20 0.32
PRMT1 Q99873 1/20 0.32
PRMT8 Q9NR22 1/20 0.32
HTR4 Q13639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530435 0.88 NCF1 (0.46) NCF1SIGMAR1CXCR4DRD3DRD2
SCHEMBL16767776 0.82 SIGMAR1 (0.38) SIGMAR1DRD3DRD2OPRM1
SCHEMBL2707078 0.80 NCF1 (0.39) NCF1BPTFCXCR4PRMT3CARM1
SCHEMBL12718264 0.80 SIGMAR1 (0.37) SIGMAR1DRD3DRD2OPRM1HTR4
SCHEMBL11445829 0.80 SIGMAR1 (0.37) SIGMAR1DRD3DRD2HTR4
SCHEMBL1075678 0.79
SCHEMBL9545164 0.76 SIGMAR1 (0.35) SIGMAR1DRD3DRD2HTR4
SCHEMBL8936092 0.75
SCHEMBL10828113 0.75
SCHEMBL7637341 0.72 SIGMAR1 (0.33) SIGMAR1DRD3DRD2OPRM1HTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5066802-A Multistep process from 2,4-difluoro-3-chloronitrobenzene and mercaptoisopropanol or mercaptopropanediol MEDIOLANUM FARMACEUTICI SRL. (IT) 1991-11-19 US disclosed
US-4923859-A Pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues MEDIOLANUM FARMACEUTICI, S.R.L. (IT) 1990-05-08 US disclosed
EP-0310969-A2 Pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1989-04-12 EP disclosed